MarketPeel
Pricing
…
RB

Robert J. Bitterman

PHIO
PRESIDENT & CEO · PHIO PHARMACEUTICALS CORP. · CIK 0001304395
FILING MIX · LIFETIME90%/10%
BUYS
28
SELLS
3
TOTAL VALUE
$86.3K
COMPANIES
1
ACTIVE SINCE
Mar 2021
HOLDINGS NOW
431,421
AVG SELL PX
$1.80
TRADE KIND
SHOWING 31 / 31
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
19 backtested trades · 8 horizons · 12 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Robert J. Bitterman, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d19+36.84%+0.90%+0.63%+0.27%-0.91%—
14d19+31.58%+0.83%+0.72%+0.11%-2.92%—
30d19+26.32%+0.82%+1.30%-0.48%-6.67%—
60d19+42.11%+0.86%+2.71%-1.85%-3.51%—
90d19+63.16%-5.53%+2.44%-7.96%+0.89%—
180d19+5.26%-35.05%+10.26%-45.31%-41.31%—
1y19(4 pending)+0.00%-68.11%+19.82%-87.93%-95.60%—
2y19(8 pending)+0.00%-90.84%+48.80%-139.64%-147.29%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
PHIO · 431,421 shares · as of Aug 18, 2026
0107,855215,711323,566431,42120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 28 buys / 3 sellsCOVERAGE · 23 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PHIO
PHIO PHARMACEUTICALS CORP.
PURCHASE
Chairman, Pres. & CEO
10,000$1.06$10.6K431,421Aug 18, 2026Aug 19, 2026 ↗View →
PHIO
PHIO PHARMACEUTICALS CORP.
PURCHASE
Chairman, Pres. & CEO
10,000$0.99$9.9K421,421Jun 26, 2026Jun 29, 2026 ↗View →
PHIO
PHIO PHARMACEUTICALS CORP.
PURCHASEGRANT
Stock grant
120,000——411,421Feb 5, 2026Feb 6, 2026 ↗View →
PHIO
PHIO PHARMACEUTICALS CORP.
PURCHASE
Chairman, Pres. & CEO
5,000$1.03$5.2K291,421Dec 31, 2025Jan 2, 2026 ↗View →
PHIO
PHIO PHARMACEUTICALS CORP.
PURCHASE
Chairman, Pres. & CEO
5,000$1.02$5.1K286,421Dec 23, 2025Dec 29, 2025 ↗View →
PHIO
PHIO PHARMACEUTICALS CORP.
PURCHASE
Chairman, Pres. & CEO
5,000$1.14$5.7K281,421Nov 21, 2025Nov 24, 2025 ↗View →
PHIO
PHIO PHARMACEUTICALS CORP.
PURCHASE
Chairman, Pres. & CEO
5,000$1.27$6.3K276,421Nov 18, 2025Nov 19, 2025 ↗View →
PHIO
PHIO PHARMACEUTICALS CORP.
PURCHASEGRANT
Stock grant
250,000——271,421Sep 11, 2025Sep 15, 2025 ↗View →
PHIO
PHIO PHARMACEUTICALS CORP.
SALE
Chairman, Pres. & CEO
4,111$2.32$9.5K21,421Sep 11, 2025Sep 15, 2025 ↗View →
PHIO
PHIO PHARMACEUTICALS CORP.
PURCHASE
Chairman, Pres & CEO
2,000$2.42$4.8K27,149Jun 10, 2025Jun 11, 2025 ↗View →
PHIO
PHIO PHARMACEUTICALS CORP.
PURCHASE
Chairman, Pres & CEO
1,500$2.75$4.1K25,149Jun 9, 2025Jun 10, 2025 ↗View →
PHIO
PHIO PHARMACEUTICALS CORP.
PURCHASE
Chairman, Pres & CEO
1,200$1.78$2.1K23,649May 22, 2025May 23, 2025 ↗View →
PHIO
PHIO PHARMACEUTICALS CORP.
PURCHASE
Chairman, Pres & CEO
3,000$1.77$5.3K22,449May 21, 2025May 23, 2025 ↗View →
PHIO
PHIO PHARMACEUTICALS CORP.
PURCHASEGRANT
Stock grant
15,500——17,832Sep 11, 2024Sep 13, 2024 ↗View →
PHIO
PHIO PHARMACEUTICALS CORP.
PURCHASE
President & CEO
1,000$0.74$74020,990Jun 7, 2024Jun 11, 2024 ↗View →
PHIO
PHIO PHARMACEUTICALS CORP.
PURCHASE
President & CEO
1,000$0.75$75019,990Jun 6, 2024Jun 10, 2024 ↗View →
PHIO
PHIO PHARMACEUTICALS CORP.
PURCHASE
President & CEO
2,500$0.91$2.3K18,990Feb 26, 2024Feb 27, 2024 ↗View →
PHIO
PHIO PHARMACEUTICALS CORP.
SALE
President & CEO
1,804$0.76$1.4K16,490Feb 20, 2024Feb 22, 2024 ↗View →
PHIO
PHIO PHARMACEUTICALS CORP.
SALE
President & CEO
917$1.51$1.4K18,294Oct 1, 2023Oct 3, 2023 ↗View →
PHIO
PHIO PHARMACEUTICALS CORP.
PURCHASE
President & CEO
1,000$2.84$2.8K19,211Jul 1, 2023Jul 5, 2023 ↗View →
PHIO
PHIO PHARMACEUTICALS CORP.
PURCHASE
President & CEO
1,000$2.88$2.9K18,211Jun 30, 2023Jul 5, 2023 ↗View →
PHIO
PHIO PHARMACEUTICALS CORP.
PURCHASEGRANT
Stock grant
11,000——17,211Feb 20, 2023Feb 22, 2023 ↗View →
PHIO
PHIO PHARMACEUTICALS CORP.
PURCHASE
Interim Executive Chairman
2,000$0.39$78074,541Dec 14, 2022Dec 15, 2022 ↗View →
PHIO
PHIO PHARMACEUTICALS CORP.
PURCHASE
Interim Executive Chairman
2,000$0.39$78072,541Dec 7, 2022Dec 8, 2022 ↗View →
PHIO
PHIO PHARMACEUTICALS CORP.
PURCHASE
Interim Executive Chairman
2,000$0.43$86070,541Dec 5, 2022Dec 6, 2022 ↗View →
PHIO
PHIO PHARMACEUTICALS CORP.
PURCHASE
Interim Executive Chairman
215$0.40$8668,541Nov 29, 2022Nov 29, 2022 ↗View →
PHIO
PHIO PHARMACEUTICALS CORP.
PURCHASE
Interim Executive Chairman
2,500$0.42$1.1K68,326Nov 25, 2022Nov 29, 2022 ↗View →
PHIO
PHIO PHARMACEUTICALS CORP.
PURCHASE
Interim Executive Chairman
1$1,750.00$1.8K1Nov 16, 2022Nov 16, 2022 ↗View →
PHIO
PHIO PHARMACEUTICALS CORP.
PURCHASEGRANT
Stock grant
40,000——65,826Oct 1, 2022Oct 3, 2022 ↗View →
PHIO
PHIO PHARMACEUTICALS CORP.
PURCHASEGRANT
Stock grant
10,000——25,826Feb 15, 2022Feb 16, 2022 ↗View →
PHIO
PHIO PHARMACEUTICALS CORP.
PURCHASEGRANT
Stock grant
10,000——15,826Mar 1, 2021Mar 3, 2021 ↗View →
Other insiders · PHIO
Loading peer insiders…
About this filer
CIK 0001304395
ROLE
President & CEO
PRIMARY
PHIO
COMPANIES
1
ACTIVE SINCE
Mar 2021
MARKETPEEL · /INSIDER/0001304395DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback